a2z Radiology AI Secures EU MDR Certification for CT Scan Detection and Reporting Software

a2z Radiology AI Inc. announced that a2z-Drafter has been certified under the EU Medical Device Regulation (MDR). The software supports triage, detection a...

November 13, 2026 | Friday | News
OncoRes Medical Rebrands as Ziva Surgical to Advance Real-Time Cancer Detection During Surgery

OncoRes Medical announced its evolution to Ziva Surgical, unveiling a new name and visual identity as the Australian tissue intelligence company enters a d...

November 13, 2026 | Friday | News
China Medical System Secures Singapore Approval for Lumirix Cream to Treat Vitiligo

China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Rxilient Medical received ...

November 05, 2026 | Thursday | News
Axplora Advances Axotecan Development to Strengthen European Exatecan Supply for ADC Manufacturers

As demand for Exatecan-based antibody-drug conjugates (ADCs) grows, securing reliable manufacturing capacity and diversified supply chains has become a pri...

October 30, 2026 | Friday | Interaction
Appian and PSI CRO Launch AI-Powered Platform to Automate Clinical Trial Site Selection

Appian (Nasdaq: APPN) and PSI CRO announced the launch of their first joint AI-powered process orchestration solution. The new offering automates clin...

October 29, 2026 | Thursday | News
CellsBin Wins NCI SBIR Award to Advance Blood-Based Multiple Myeloma Test

CellsBin®, a biotechnology company pioneering Rare-Cell Biology™, announced that it has received a Direct-to-Phase II Small Business Innov...

October 29, 2026 | Thursday | News
GrOwnValve Achieves Primary Safety Endpoint in First Five Patients in Heart Valve Study

GrOwnValve GmbH, a Berlin-based medical technology company developing personalized heart valves from patients' own tissue, announced the achievement of t...

October 28, 2026 | Wednesday | News
SystImmune and Bristol Myers Squibb’s Iza-Bren Extends Progression-Free Survival in Phase 3 Lung Cancer Trial

Late-breaking results to be presented in an oral presentation at ESMO 2026 PANKU-Lung01 is the first Phase 3 trial to evaluate a dual-targeting EGFRxHER...

October 27, 2026 | Tuesday | News
BioAgilytix Expands Global Bioanalytical Capabilities Through New 360biolabs Sydney Laboratory

BioAgilytix, a  global bioanalytical Contract Research Organization (CRO), announces the expansion of its  Australian laboratories through the op...

October 27, 2026 | Tuesday | News
Takeda’s Arcotatug Tavat​​ecan Meets Dual Primary Endpoints in Phase 3 Gastric Cancer Trial

Data from the Registrational Phase 3 G-HOPE-001 Study of Arcotatug Tavatecan, a Novel, Potential Best-in-Class Claudin (CLDN)18.2 ADC, were Highlighted...

October 26, 2026 | Monday | News
Gesynta Pharma Completes Phase 2 Endometriosis Trial Enrolment Ahead of Schedule

Gesynta Pharma AB, a clinical-stage biotech company developing vipoglanstat, a non-hormonal, non-opioid therapy that could transform the standard of care f...

October 21, 2026 | Wednesday | News
Lilly’s Omvoh Meets Primary Endpoint in Phase 3 Paediatric Ulcerative Colitis Trial

Building on Omvoh's approved use and durable efficacy in adults, Lilly plans to submit these data to global regulators to support a potential label expansi...

October 20, 2026 | Tuesday | News
OSE Immunotherapeutics Reports Positive Phase 2 Results for Tedopi in Metastatic Lung Cancer

Topline results to be presented by Federico Cappuzzo, MD, PhD, on October 25, 2026, at the Annual Meeting of the European Society for Medical Oncology (E...

October 20, 2026 | Tuesday | News
Evaxion Reports Sustained Three-Year Responses with EVX-01 in Advanced Melanoma

Three-year data from the EVX-01 phase 2 trial in patients with advanced melanoma to be presented at the ESMO 2026 Congress Data supplements unprecedente...

October 20, 2026 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close